Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

European Commission approves new indication for AstraZeneca antiasthmatic

Jan. 17, 2000

Respiratory disease collaboration ended by mutual agreement by Millennium and AstraZeneca

Jan. 13, 2000

Agents for cough in development at Nortran as alternatives to codeine

Jan. 13, 2000

Millennium licenses chronic asthma treatment to Taisho

Jan. 11, 2000

New series of NK2 receptor antagonists developed at Pfizer

Jan. 10, 2000

Zambon and Sheffield begin clinical program for MSI-ipratropium

Jan. 6, 2000

New nonpeptide compound AY-0068 is a potent, selective and metabolically stable tryptase inhibitor

Jan. 4, 2000

Inspire and UNC describe method of enhancing airways mucus secretion

Jan. 4, 2000

Avanir's new benzimidazole analogues inhibit IgE response to allergens

Jan. 4, 2000

Preclinical pharmacokinetics of SB-240563 support clinical development for asthma

Jan. 3, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...